کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
10909291 1087849 2011 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma
چکیده انگلیسی
NT-proBNP provides diagnostic and prognostic information in heart syndromes but its role in cancer has not yet been established. The prognostic value of NT-proBNP was prospectively studied in 104 non-Hodgkin lymphoma (NHL) patients treated with chemotherapy. Echocardiography and NT-proBNP were determined prior to treatment. In multivariate analysis, NT-proBNP ≥ 900 pg/ml was the variable with higher risk of death (adjusted hazard ratio 11.1; 95% CI 3.8-32.9; P < 0.001). The C statistic for NT-proBNP ≥ 900 pg/ml was significantly better than IPI score for prediction of survival. These findings suggest that NT-proBNP ≥ 900 pg/ml could be considered a useful marker for risk assessment in NHL patients treated with chemotherapy.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Leukemia Research - Volume 35, Issue 6, June 2011, Pages 715-720
نویسندگان
, , , , , , , , , , , , ,